Skip to main navigation Skip to search Skip to main content

Investigators at Hanyang University Target Tyrosine Kinase Inhibitors (Development and Optimization of Sorafenib Nanosuspension By High-pressure Homogenization for Improved Oral Bioavailability)

Press/Media

Period2026.09.29

Media coverage

1

Media coverage

  • TitleInvestigators at Hanyang University Target Tyrosine Kinase Inhibitors (Development and Optimization of Sorafenib Nanosuspension By High-pressure Homogenization for Improved Oral Bioavailability)
    Media name/outletSouth Korea Daily Report
    Country/TerritoryUnited States
    Date26.09.29
    PersonsKihyun Kim